Biomarkers, Pharmacological
"Biomarkers, Pharmacological" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurable biological parameters that serve for drug development, safety and dosing (DRUG MONITORING).
| Descriptor ID |
D054316
|
| MeSH Number(s) |
D23.101.137
|
| Concept/Terms |
Biomarkers, Pharmacological- Biomarkers, Pharmacological
- Pharmacological Biomarkers
- Biological Markers, Pharmacological
- Markers, Pharmacological Biological
- Pharmacological Biological Markers
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers, Pharmacological".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers, Pharmacological".
This graph shows the total number of publications written about "Biomarkers, Pharmacological" by people in this website by year, and whether "Biomarkers, Pharmacological" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2017 | 4 | 7 | 11 |
| 2018 | 2 | 6 | 8 |
| 2020 | 2 | 1 | 3 |
| 2021 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Biomarkers, Pharmacological" by people in Profiles.
-
Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial. J Clin Pharmacol. 2021 11; 61(11):1406-1414.
-
Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction. Allergy Asthma Proc. 2021 05 01; 42(3):187-197.
-
Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population. J Thromb Thrombolysis. 2021 May; 51(4):902-904.
-
Tocilizumab in COVID-19 interstitial pneumonia. J Intern Med. 2021 05; 289(5):738-746.
-
Filter clotting with continuous renal replacement therapy in COVID-19. J Thromb Thrombolysis. 2021 May; 51(4):966-970.
-
Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome. Scand J Rheumatol. 2020 09; 49(5):414-416.
-
Late onset infectious complications and safety of tocilizumab in the management of COVID-19. J Med Virol. 2021 03; 93(3):1459-1464.
-
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. J Immunother Cancer. 2020 08; 8(2).
-
A Real-World Evidence Framework for Optimizing Dosing in All Patients With COVID-19. Clin Pharmacol Ther. 2020 11; 108(5):921-923.
-
Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria. J Immunol Res. 2018; 2018:5615109.